NCT04635852View on ClinicalTrials.gov

Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
CancerDyspnea, Paroxysmal
Interventions
DRUG

Fentanyl

DRUG

Immediate release morphine

Trial Locations (3)

37075

University Hospital Göttingen Center of Palliative Medicine, Göttingen

45136

Hospital Essen- Mitte, Departement of Palliative Medicine, Essen

50937

Study Center Palliative Medicine, Cologne

All Listed Sponsors
collaborator

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

lead

University of Cologne

OTHER

NCT04635852 - Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients | Biotech Hunter | Biotech Hunter